Bio-Rad Laboratories posted its fourth quarter adjusted earnings of $3.31 per share, which is below the Zacks Consensus Estimate of $3.45 per share (according to Zacks Equity Research). Earnings were $3.21 per share a year ago. Over the last four quarters, the company exceeded consensus EPS expectations three times.
Revenues came in at $730.29 million, vs. $732.77 million a year ago, and missing the Zacks Consensus Estimate by 2.93%. The company beat consensus revenue estimates two times over the last four quarters (according to Zacks Equity Research).